By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MpkonnectMpkonnect
  • Home
  • Recent Stories
  • Guest Columns
  • Gallery
Reading: Cipla and Glenmark Drug Recalls Signal Quality Concerns: A Wake-Up Call for Indian Pharma Industry
Share
Sign In
Notification Show More
Latest News
Bhopal to Host 21st World Rose Convention in 2028: India to Welcome Global Rose Enthusiasts for the First Time
May 29, 2025
Ather Energy Expands Madhya Pradesh Presence with Second Experience Centre in Indore
May 27, 2025
CtrlS Commits ₹500 Crore to Build Greenfield Data Center in Bhopal
May 15, 2025
PVR INOX Makes Grand Entry into Jabalpur with First Multiplex at KA Mall under FOCO Model
May 14, 2025
SECI Floats Tender for Balance of System Package for 200 MW Solar Project in Madhya Pradesh
May 11, 2025
Aa
MpkonnectMpkonnect
Aa
Search
  • Categories
  • Bookmarks
  • More Foxiz
    • Sitemap
Have an existing account? Sign In
Follow US
  • Contact
  • Blog
  • Complaint
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Mpkonnect > Blog > Business > Cipla and Glenmark Drug Recalls Signal Quality Concerns: A Wake-Up Call for Indian Pharma Industry
Business

Cipla and Glenmark Drug Recalls Signal Quality Concerns: A Wake-Up Call for Indian Pharma Industry

admin May 6, 2024
Updated 2024/05/06 at 8:07 AM
Share
2 Min Read
SHARE

The US Food and Drug Administration (USFDA) has recently presented worries about manufacturing attempts at abilities run by two sizable Indian pharmaceutical organizations, Cipla and Glenmark. The recalls that these businesses started from the US market have highlighted possible value issues in the common medication sector in India and raised concerns about agreements with international models.

The “short fill” problems that controlled the memory of 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution by Cipla, which was fashioned at its Indore SEZ factory, have been related to protests of insufficient volume and liquid outflows in the wrapping. Similar to this, Glenmark Pharma has recalled 3,264 bottles of Diltiazem Hydrochloride extended-release pills that were meant to treat high blood pressure because they “failed dissolution specifications.”

The USFDA has categorized these callbacks as Class II because they raise inquiries about patient safety and product effectiveness since using the wedged products may have temporary or flexible negative health results. 

With over 60,000 common products produced in 60 medicinal categories, India is the world’s largest supplier of universal medications yet is under fire for its pharmaceutical ships. Instances such as these memories emphasize the requirement of strict value control methods to preserve sincerity and trust in Indian pharmaceutical products, even if the country makes a considerable impact on the global pharmaceutical market.

India is a key global seller of pharmaceuticals, reaching more than 200 nations, with Western Europe, the US, and Japan. Consequently, governing standards must be followed at all times. The nation is home to the greatest number of USFDA-compliant businesses with operations outside of the US, highlighting the importance of continuing expansion and interest in detail in manufacturing processes. 

The recent memories should act as a wake-up call for the Indian pharmaceutical industry, and influence it to place a higher priority on controlling compliance and excellence declaration to protect public health and uphold its standing as a top supplier of reasonably priced generic drugs internationally.

 

You Might Also Like

Bhopal to Host 21st World Rose Convention in 2028: India to Welcome Global Rose Enthusiasts for the First Time

Ather Energy Expands Madhya Pradesh Presence with Second Experience Centre in Indore

CtrlS Commits ₹500 Crore to Build Greenfield Data Center in Bhopal

PVR INOX Makes Grand Entry into Jabalpur with First Multiplex at KA Mall under FOCO Model

SECI Floats Tender for Balance of System Package for 200 MW Solar Project in Madhya Pradesh

TAGGED: cipla, glenmark, indore, useda

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
admin May 6, 2024
Share this Article
Facebook TwitterEmail Print
Share
Posted by admin
Follow:
Mpkonnect
Previous Article Madhya Pradesh Unveils Pranpur: India’s First Craft Handloom Tourism Village
Next Article Shivpuri: the forgotten gem of Madhya Pradesh
Leave a comment Leave a comment

Leave a Reply Cancel reply

Login with your Social ID

Your email address will not be published. Required fields are marked *

Stay Connected

3.2k Followers Like
30 Followers Follow
232 Subscribers Subscribe
- Advertisement -
Ad imageAd image

Latest News

Bhopal to Host 21st World Rose Convention in 2028: India to Welcome Global Rose Enthusiasts for the First Time
Business May 29, 2025
Ather Energy Expands Madhya Pradesh Presence with Second Experience Centre in Indore
Business May 27, 2025

You Might also Like

Business

Bhopal to Host 21st World Rose Convention in 2028: India to Welcome Global Rose Enthusiasts for the First Time

May 29, 2025
Business

Ather Energy Expands Madhya Pradesh Presence with Second Experience Centre in Indore

May 27, 2025
Business

CtrlS Commits ₹500 Crore to Build Greenfield Data Center in Bhopal

May 15, 2025
Business

PVR INOX Makes Grand Entry into Jabalpur with First Multiplex at KA Mall under FOCO Model

May 14, 2025
//

We work on the idea of creating a community of MPites or are working or settled in different parts of the state, country and/ or the world. It is a platform for the professional advisory, knowledge sharing & business networking for the like minded people.

 

Quick Link

  • Advertise with us
  • Newsletters
  • Deal

Top Categories

  • Market Place
  • Guest Columns

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

I have read and agree to the terms & conditions
MpkonnectMpkonnect

© 2022 MPkonnect . All Rights Reserved.

  •  

  •  

  •  

  •  

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Register Lost your password?